Wolverine Trading’s Co-Diagnostics CODX Stock Holding History

Wolverine Trading’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-393	Closed	-$8.26K	–	4877
2024 Q4	$8.26K	Buy	+393	New	+$12.4K	﹤0.01%	5164
2023 Q1	–	Sell	-520	Closed	-$39K	–	4320
2022 Q4	$39K	Buy	+520	New	+$48.7K	﹤0.01%	3627
2022 Q3	–	Sell	-580	Closed	-$93K	–	4683
2022 Q2	$93K	Sell	580 -277	-32%	-$42.1K	﹤0.01%	3865
2022 Q1	$163K	Sell	857 -363	-30%	-$75.2K	﹤0.01%	4552
2021 Q4	$332K	Sell	1,220 -897	-42%	-$235K	﹤0.01%	4005
2021 Q3	$618K	Sell	2,117 -460	-18%	-$134K	﹤0.01%	3626
2021 Q2	$689K	Buy	2,577 +430	+20%	+$111K	﹤0.01%	3254
2021 Q1	$550K	Sell	2,147 -353	-14%	-$141K	﹤0.01%	3568
2020 Q4	$730K	Buy	2,500 +247	+11%	+$91.5K	﹤0.01%	2741
2020 Q3	$941K	Buy	2,253 +183	+9%	+$94K	﹤0.01%	2147
2020 Q2	$1.08M	Buy	+2,070	New	+$945K	﹤0.01%	1925

Other funds holding CODX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAG

Private Advisory Group Redmond, Washington $1.52B AUM 41.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

Wolverine Trading's CODX Position: Q1 2025 in Review

Wolverine Trading sold out of Co-Diagnostics (CODX) in Q1 2025, closing a stake of 451 shares — an estimated $9.46K sold.

Wolverine Trading first reported a position in CODX in Q2 2020 and held it in 8 quarters. The position peaked at $302K in Q3 2020. 38 funds tracked by Wall St. Rank hold CODX as of Q1 2025.

Wolverine Trading reported no remaining Co-Diagnostics position as of Q1 2025 after selling out during the quarter.
Wolverine Trading sold 451 Co-Diagnostics shares in Q1 2025, an estimated $9.46K.
Wolverine Trading first reported a position in Co-Diagnostics in Q2 2020 and held it in 8 quarters.
Wolverine Trading's Co-Diagnostics position peaked at $302K in Q3 2020.
38 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2025.

Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.